Loading clinical trials...

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines | Clinical Trials | Clareo Health

COMPLETEDPHASE4

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

NCT00856414•Allergan

View on ClinicalTrials.gov

Summary

This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)

Eligibility

Age

35 - 55 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Female subjects of any race, 35-55 years of age
•Moderate to severe glabellar wrinkles (lines between the eyebrows)

Exclusion Criteria

•Previous botulinum toxin therapy
•Subjects who are pregnant, breast-feeding, or who are of childbearing potential and not practicing a reliable method of birth control
•Subjects planning a facial cosmetic procedure or visible scars
•Previous cosmetic surgery to the upper face
•Medical condition that may increase their risk of exposure to botulinum toxin including diagnosed Myasthenia Gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis, or any other disease that might interfere with neuromuscular function
•History of facial nerve palsy
•Allergy or sensitivity to any component of the study medication

Locations (2)

West Palm Beach, Florida, United States

Livonia, Michigan, United States

Key Dates

Start Date

March 1, 2009

Primary Completion Date

April 1, 2009

Completion Date

April 1, 2009

Last Updated

January 29, 2019

Enrollment

ACTUAL participants

Conditions

Skin Aging

Interventions

botulinum toxin Type A

BIOLOGICAL

MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology

NCT07261748

Aesthetic ProceduresCosmetic Techniques+2 more

View study

ACTIVE_NOT_RECRUITINGNA

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging

NCT06804759

Skin Aging

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Inclusion Criteria

Exclusion Criteria

MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging

Efficacy and Safety of NP-2007 on Skin Health

A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies

A Clinical Study Testing How Well the Medical Device HTIC (a Type of Animal-derived Collagen) Works in Treating Skin Problems, Such as Scars, Loss of Firmness, and Volume in Certain Areas of the Face and Body

Efficacy Study of Oral Collagen Peptide on Skin Condition Improvement